From Yahoo Finance: 2025-06-04 22:33:00

Elon Musk’s company Tesla is preparing to launch its fleet of autonomous robotaxis, a pivotal event for the electric vehicle producer. Despite recent growth, TSLA stock is still recovering from market share losses.

Neuralink, one of Musk’s startups, recently closed a successful Series E funding round, raising $650 million. The company is making strides in brain interface technology, allowing individuals with severe paralysis to control devices with their thoughts.

Neuralink faces competition from Paradromics, which tested a brain implant in a human patient with epilepsy. Both companies are vying for a leading position in the emerging brain chip market, which analysts predict could be worth $1 billion annually by 2041.

Neuralink is conducting clinical trials at top neurosurgical facilities worldwide to expand its technology’s capabilities and unlock new human potential. This recent funding round will support the company as it advances in the competitive neurotech industry.

As Musk’s ventures in brain chip technology progress, the public’s trust in this innovative medical treatment approach is expected to grow over time. The neurotech startups are working to revolutionize medical treatment and pave the way for groundbreaking advancements in brain interface technology.

Read more: Elon Musk company reveals major leap forward